PL374263A1 - Rekombinowane endonukleazy restrykcyjne typu II, endonukleaza MmeI i endonukleazy pokrewne oraz sposoby ich wytwarzania - Google Patents

Rekombinowane endonukleazy restrykcyjne typu II, endonukleaza MmeI i endonukleazy pokrewne oraz sposoby ich wytwarzania

Info

Publication number
PL374263A1
PL374263A1 PL03374263A PL37426303A PL374263A1 PL 374263 A1 PL374263 A1 PL 374263A1 PL 03374263 A PL03374263 A PL 03374263A PL 37426303 A PL37426303 A PL 37426303A PL 374263 A1 PL374263 A1 PL 374263A1
Authority
PL
Poland
Prior art keywords
endonucleases
mmei
producting
methods
same
Prior art date
Application number
PL03374263A
Other languages
English (en)
Other versions
PL208400B1 (pl
Inventor
Richard D. Morgan
Tanya Bhatia
Theodore Davis
Lindsay Lovasco
Original Assignee
New England Biolabs, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Biolabs, Inc. filed Critical New England Biolabs, Inc.
Publication of PL374263A1 publication Critical patent/PL374263A1/pl
Publication of PL208400B1 publication Critical patent/PL208400B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
PL374263A 2002-07-12 2003-07-10 Wyizolowany segment DNA kodujący MmeI restrykcyjna endonukleaza-metylaza, rekombinowany wektor, komórka gospodarza transformowana wektorem i sposób wytwarzania rekombinowanej endonukleazy restrykcyjnej MmeI oraz metylazy MmeI PL208400B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39543102P 2002-07-12 2002-07-12

Publications (2)

Publication Number Publication Date
PL374263A1 true PL374263A1 (pl) 2005-10-03
PL208400B1 PL208400B1 (pl) 2011-04-29

Family

ID=30115870

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374263A PL208400B1 (pl) 2002-07-12 2003-07-10 Wyizolowany segment DNA kodujący MmeI restrykcyjna endonukleaza-metylaza, rekombinowany wektor, komórka gospodarza transformowana wektorem i sposób wytwarzania rekombinowanej endonukleazy restrykcyjnej MmeI oraz metylazy MmeI

Country Status (7)

Country Link
US (1) US7115407B2 (pl)
EP (2) EP2228442A1 (pl)
CN (2) CN101693898A (pl)
AU (1) AU2003253865A1 (pl)
DE (1) DE60332739D1 (pl)
PL (1) PL208400B1 (pl)
WO (1) WO2004007670A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186538B2 (en) 2003-07-10 2007-03-06 New England Biolabs, Inc. Type II restriction endonuclease, CstMI, obtainable from Corynebacterium striatum M82B and a process for producing the same
US7932029B1 (en) * 2006-01-04 2011-04-26 Si Lok Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities
US8361774B2 (en) * 2006-12-27 2013-01-29 New England Biolabs, Inc. Recombinant type II restriction endonuclease, NmeAIII, and a process for producing the same
US8620589B2 (en) * 2007-06-20 2013-12-31 New England Biolabs, Inc. Synthetic binding proteins
EP2158556A2 (en) 2007-06-20 2010-03-03 New England Biolabs, Inc. Rational design of binding proteins that recognize desired specific squences
EP2390315B1 (en) * 2007-07-12 2014-11-19 New England Biolabs, Inc. High fidelity restriction endonucleases
US8741570B2 (en) * 2008-02-06 2014-06-03 Ludwig-Maximilians-Universitat Munchen Thermo-optical characterisation of nucleic acid molecules
WO2010075375A1 (en) 2008-12-23 2010-07-01 New England Biolabs, Inc. Compositions, methods and related uses for cleaving modified dna
DE102018107585B3 (de) * 2018-03-29 2019-03-28 Universität Rostock Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0066994A3 (en) 1981-06-04 1984-02-01 Imperial Chemical Industries Plc Production and use of genetically-modified microorganisms
US5200333A (en) 1985-03-01 1993-04-06 New England Biolabs, Inc. Cloning restriction and modification genes
WO1999011821A1 (en) 1997-09-02 1999-03-11 New England Biolabs, Inc. Method for screening restriction endonucleases
US6413758B1 (en) * 2000-10-20 2002-07-02 New England Biolabs, Inc. Method for cloning and expression of Bpml restriction endonuclease in E. coli
US7186538B2 (en) 2003-07-10 2007-03-06 New England Biolabs, Inc. Type II restriction endonuclease, CstMI, obtainable from Corynebacterium striatum M82B and a process for producing the same

Also Published As

Publication number Publication date
PL208400B1 (pl) 2011-04-29
EP1539945A2 (en) 2005-06-15
WO2004007670A3 (en) 2004-03-25
EP1539945A4 (en) 2006-01-04
US20040091911A1 (en) 2004-05-13
WO2004007670A2 (en) 2004-01-22
DE60332739D1 (de) 2010-07-08
CN100591765C (zh) 2010-02-24
CN1668740A (zh) 2005-09-14
EP2228442A1 (en) 2010-09-15
AU2003253865A1 (en) 2004-02-02
CN101693898A (zh) 2010-04-14
EP1539945B1 (en) 2010-05-26
US7115407B2 (en) 2006-10-03
AU2003253865A8 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
EG25097A (en) Piprazinyl and diazapanyl benzamides and benzthioamides.
AU2003265853A8 (en) Hedgehog antagonists, methods and uses related thereto
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
IL162266A0 (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the useof the same
IL164687A0 (en) Cellular libraries and methods for the preparationthereof
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
AU2003268536A1 (en) Wireless game device and method for using the same
EG24579A (en) Herbicide composition and weed-controlling method using the same
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
HK1065652A1 (en) Antenna and method for manufacturing the same
SI1551805T1 (sl) Substituirani gama-fenil-delta-laktami in njihova uporaba
AU2003253865A8 (en) Recombinant type ii restriction endonucleases, mmei and related endonucleases and methods for producting the same
GB2370808B (en) Laminates and methods for manufacturing the same
EP1517879A4 (en) AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE
HK1061655A1 (en) Caloporoside derivatives, methods for the production thereof and their use
GB0312340D0 (en) Improved game and aricle for use with the game
GB0106782D0 (en) Polypeptides, methods and means
GB0226181D0 (en) The reach all
GB0202011D0 (en) The Fucker
GB0218300D0 (en) The planit game
GB0223611D0 (en) N,o-oversulfated-k5-derivatives and copd
AU2003251425A8 (en) Mahoganoid polypeptides, and related compositions and methods
GB0208846D0 (en) The moke
SI1372670T1 (en) Caloporoside derivatives, methods for the production thereof and their use
GB0225448D0 (en) Perfect points

Legal Events

Date Code Title Description
RECP Rectifications of patent specification
LAPS Decisions on the lapse of the protection rights

Effective date: 20130710